TipRanks
Go Ultimate55% OFF

Green Future Food Hydrocolloid Marine Science Co., Ltd. (1084) AI Stock Analysis

HK:1084

Green Future Food Hydrocolloid Marine Science Co., Ltd.

(HKEX:1084)

Select Model
Rating:44Neutral
Price Target:HKD 0.62â–¼(-1.43% Downside)
Action:reiterated
Date:10/03/26

The overall score reflects weak but stabilizing fundamental performance, where revenue recovery is outweighed by razor-thin margins, deteriorating cash generation, and low ROE, combined with a technically weak price trend that is oversold rather than convincingly improving, and a stretched valuation with a high earnings multiple and modest yield that offers limited downside protection.

Positive Factors
Revenue GrowthThe strong 2025 revenue rebound indicates renewed demand for the company’s hydrocolloid ingredients and improved commercial activity. If sustained, higher sales can support better capacity utilization, customer penetration, and operating leverage across the ingredient business over the coming quarters.
Negative Factors
Margin CompressionThe sharp decline in both gross and net margins shows that revenue growth is currently producing little profit. Persistent margin pressure would weaken reinvestment capacity, reduce resilience against operating fluctuations, and make future earnings increasingly dependent on a meaningful profitability recovery.

Green Future Food Hydrocolloid Marine Science Co., Ltd. (1084) vs. iShares MSCI Hong Kong ETF (EWH)

-5%0%5%10%15%20%HK:1084+1.94%EWH+7.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
HKD 546.28M
Dividend Yield
1.90%
Average Volume (3M)
64.83K
Price to Earnings (P/E)
36.6
Beta (1Y)
0.02
Revenue Growth
13.36%
EPS Growth
-37.89%
Country
Hong Kong
Employees
1,030
Sector
Consumer Defensive
Sector Strength
62
Industry
Agricultural Farm Products

Green Future Food Hydrocolloid Marine Science Co., Ltd. Business Overview & Revenue Model

Company Description

Green Fresh Biotechnology Co., Ltd. operates as an investment holding entity with its core business focused on the manufacturing and distribution of hydrocolloid products for the food industry. The company's activities are organized across distinct p...

How the Company Makes Money

The company primarily makes money by selling marine hydrocolloid ingredients to business customers (e.g., food processors and manufacturers) that use these inputs to improve texture, stability, and shelf life in finished products. Key revenue streams...

Green Future Food Hydrocolloid Marine Science Co., Ltd. Financial Statement Overview

Summary

Revenue has recovered but profitability is very weak, with net margin falling to 0.7% and gross margin declining to 18%, while negative operating and free cash flow and sharply lower ROE indicate strained earnings quality despite a relatively stable, well-capitalized balance sheet.

Income Statement

42Neutral

Balance Sheet

65Positive

Cash Flow

28Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue905.55M904.35M988.64M1.17B1.64B1.16B
Gross Profit167.35M167.16M222.32M37.64M434.72M259.97M
EBITDA83.96M83.67M158.18M-28.75M382.23M211.36M
Net Income6.56M6.59M62.13M-85.33M199.23M103.62M
Balance Sheet
Total Assets1.63B1.63B1.57B1.54B1.89B1.70B
Cash, Cash Equivalents and Short-Term Investments88.64M108.40M120.66M84.10M43.50M139.36M
Total Debt592.85M593.10M564.77M601.97M649.27M624.50M
Total Liabilities785.20M785.53M721.67M789.49M938.99M837.68M
Stockholders Equity838.69M839.05M839.35M745.24M945.20M841.98M
Cash Flow
Free Cash Flow-18.78M-45.42M62.77M84.75M-82.78M-16.41M
Operating Cash Flow7.01M-20.34M128.71M96.52M-32.19M61.11M
Investing Cash Flow-25.42M-25.00M-43.75M-6.96M-51.60M-137.17M
Financing Cash Flow-12.73M14.13M-37.50M-55.20M-5.01M99.46M

Green Future Food Hydrocolloid Marine Science Co., Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price0.63

Price Trends

50DMA0.66Negative
100DMA0.67Negative
200DMA0.66Negative

Market Momentum

MACD-0.01Negative
RSI37.28Neutral
STOCH75.00Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1084, the sentiment is Negative. The current price of 0.63 is below the 20-day moving average (MA) of 0.64, below the 50-day MA of 0.66, and below the 200-day MA of 0.66, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 37.28 is Neutral, neither overbought nor oversold. The STOCH value of 75.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1084.

Green Future Food Hydrocolloid Marine Science Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

HK:1084 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:2497HK:249774OutperformHKD 247.50M3.6910.28%―――
HK:1936HK:193669NeutralHKD 1.92B81.298.24%―11.92%46.15%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
HK:2419HK:241954NeutralHKD 8.69B-17.95-12.23%1.76%-10.01%-129.99%
HK:1084HK:108444NeutralHKD 542.98M36.621.52%1.90%13.36%-37.89%
HK:0682HK:068241NeutralHKD 39.55M-1.89-9.20%―-6.52%-3.96%

* Consumer Defensive Sector Average

Performance Comparison

0%200%400%600%HK:1084HK:0682HK:1936HK:2419HK:2497Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
HK:1084 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:1084Green Future Food Hydrocolloid Marine Science Co., Ltd.0.63-0.01-1.25%
HK:0682Chaoda Modern Agriculture Holdings Ltd.0.20-0.07-24.53%
HK:1936Ritamix Global Limited4.073.49599.31%
HK:2419Dekon Food And Agriculture Group Class H55.00-16.85-23.45%
HK:2497Fujing Holdings Company., Limited0.49-0.15-22.66%

Green Future Food Hydrocolloid Marine Science Co., Ltd. Corporate Events

Green Fresh Biotechnology Corrects Share Award Scheme Figures in Interim Results

Sep 4, 2026

Green Fresh Biotechnology Company Limited has issued a supplemental announcement to clarify figures disclosed in its 2026 interim results regarding its share award scheme. The company stated that the number of shares held by the trustee and available...

Green Fresh Biotechnology Narrows Interim Loss as Revenue Jumps 30%

Aug 31, 2026

Green Fresh Biotechnology Company Limited reported a strong top-line performance for the six months ended 30 June 2026, with revenue rising 30.4% year-on-year to RMB534.8 million. Gross profit increased to RMB75.8 million, although gross margin edged...

Green Fresh Biotechnology Sets Board Meeting on Interim Results and Dividend

Aug 19, 2026

Green Fresh Biotechnology Company Limited, a Cayman Islands-incorporated biotechnology firm listed in Hong Kong, is led by Chairman and CEO Chan Kam Chung together with both executive and independent non-executive directors. The company operates thro...

Green Fresh Biotechnology Narrows Interim Loss on Strong Carrageenan Sales

Aug 12, 2026

Green Fresh Biotechnology has signalled a sharp narrowing of its interim net loss for the six months ended 30 June 2026, expecting a loss of RMB1.0 million to RMB4.0 million versus RMB12.07 million a year earlier. The improvement stems mainly from hi...

Green Fresh Sandwich Box Wins Spot on Hong Kong Green Tableware Platform

Jul 8, 2026

Green Fresh Biotechnology Company Limited has secured approval for its BOTEC-branded eco-friendly sandwich box with a transparent window to be listed on Hong Kong’s Environmental Protection Department Green Tableware Platform. The product, supp...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 03, 2026